Acadia Healthcare Company, Inc. (ACHC)
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
- Symbol
- ACHC
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Market cap
- $2.59B
- 52 week range
- 11.43 - 35.83
Valuation
- Share price
- $28.51 (close of 2026-09-23)
- P/E (TTM)
- -2.34x
- Price to book
- 1.32x
- Price to free cash flow
- -8.87x
- Enterprise value
- $5.10B
- Book value per share
- $21.58
Price performance
| Period | Change |
|---|
| 1 day | +0.49% |
| 5 days | +4.13% |
| 1 month | +2.48% |
| 3 months | +16.18% |
| 6 months | +22.99% |
| Year to date | +100.92% |
| 1 year | +29.47% |
| 3 years | -59.36% |
| 5 years | -56.24% |
| 10 years | -42.45% |
| All time | +18.79% |
Profitability and growth
- Return on equity
- -56.58%
- Return on assets
- -19.95%
- Net margin
- -33.29%
- EBITDA margin
- -26.79%
- Revenue growth
- 5.04%
- Net income growth
- -531.42%
- Free cash flow growth
- 21.54%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- -11.28%
- Current ratio
- 1.71x
- Net debt to EBITDA
- -3.46x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $3.31B
- EBITDA
- $-887.54M
- Net income
- $-1.10B
- Earnings per share
- $-12.16
- Shares outstanding
- 90.70M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $3.31B | - | $-1.10B | $-12.16 |
| 2024-12-31 | $3.15B | - | $255.61M | $2.79 |
| 2023-12-31 | $2.93B | - | $-21.67M | $-0.24 |
| 2022-12-31 | $2.61B | - | $273.14M | $3.05 |
| 2021-12-31 | $2.31B | - | $190.63M | $2.15 |
| 2020-12-31 | $2.09B | - | $-672.13M | $-7.65 |
| 2019-12-31 | $2.01B | $676.28M | $108.92M | $1.24 |
| 2018-12-31 | $1.90B | $680.18M | $-175.75M | $-2.01 |
| 2017-12-31 | $2.84B | $680.76M | $199.84M | $2.30 |
| 2016-12-31 | $2.81B | $695.39M | $6.14M | $0.07 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | - | -33.29% | -56.58% | - |
| 2024-12-31 | - | 8.10% | 8.32% | - |
| 2023-12-31 | - | -0.74% | -0.78% | - |
| 2022-12-31 | - | 10.46% | 9.71% | - |
| 2021-12-31 | - | 8.24% | 7.57% | - |
| 2020-12-31 | - | -32.16% | -35.39% | - |
| 2019-12-31 | 33.67% | 5.42% | 4.35% | 9.83% |
| 2018-12-31 | 35.71% | -9.23% | -7.53% | 10.66% |
| 2017-12-31 | 24.00% | 7.05% | 7.77% | 9.87% |
| 2016-12-31 | 24.74% | 0.22% | 0.28% | 10.74% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $133.24M | $2.47B |
| 2024-12-31 | $76.31M | $1.88B |
| 2023-12-31 | $100.07M | $1.34B |
| 2022-12-31 | $97.65M | $1.36B |
| 2021-12-31 | $133.81M | $1.48B |
| 2020-12-31 | $378.70M | $2.97B |
| 2019-12-31 | $99.53M | $3.11B |
| 2018-12-31 | $50.51M | $3.16B |
| 2017-12-31 | $67.29M | $3.21B |
| 2016-12-31 | $57.06M | $3.25B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $-439.91M | $31.71M |
| 2024-12-31 | $-560.69M | $37.11M |
| 2023-12-31 | $38.21M | $32.29M |
| 2022-12-31 | $84.42M | $29.64M |
| 2021-12-31 | $129.67M | $37.53M |
| 2020-12-31 | $433.84M | $22.50M |
| 2019-12-31 | $100.22M | $17.31M |
| 2018-12-31 | $160.89M | $22.00M |
| 2017-12-31 | $125.40M | $23.47M |
| 2016-12-31 | $54.01M | $28.34M |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-04
- Consensus EPS estimate
- $0.47
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-07-28 | Jun/2026 | $0.33 |
| 2026-04-29 | - | - |
| 2026-02-25 | - | - |
| 2025-11-05 | - | - |
| 2025-08-05 | - | - |
| 2025-05-12 | - | - |
| 2025-02-27 | - | - |
| 2025-02-25 | - | - |
Filings and sources
- Company website
- acadiahealthcare.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Vertex Pharmaceuticals Inc (VRTX) · Regeneron Pharmaceuticals, Inc. (REGN) · Moderna, Inc. (MRNA) · Incyte Corp (INCY) · Bio-Techne Corp (TECH)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades